Suvoda Launches eCOA-Specific Language and Design Toolkit
Suvoda announced that as part of its single platform rollout, its eCOA solution is moving to the second phase of the Early Adopter program. This solution, designed to work with Suvoda IRT and eConsent, focuses on addressing eCOA challeneges such as gaps in overall delivery and execution quality, time consuming translations and localization processes, and logistics related to device management.
Read more about the solution here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Twice-Yearly Lenacapavir Injections Significantly Reduce HIV Risk, PURPOSE 2 Trial Shows
November 13th 2024Full Phase III PURPOSE 2 trial results suggest that twice-yearly lenacapavir could revolutionize HIV prevention by offering a convenient and effective long-acting option for individuals at risk of infection.
